Brief: Norris Medicines Says Profitability Of Co Likely To Be Adversely Impacted Due To COVID-19 Pandemic
June 1 (Reuters) - Norris Medicines Ltd NORI.BO :
* REVENUES AND PROFITABILITY OF CO LIKELY TO BE ADVERSELY
IMPACTED
DUE TO COVID-19 PANDEMIC
* EXPECTS TO REACH NEAR NORMAL OPERATIONS FROM Q3
Source text for Eikon: ID:nBSE89sJcK
Further company coverage: NORI.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Norris Medicines
See all newsBrief: Norris Medicines Iqubal Patel Resigns As CFO
Brief: Norris Medicines Successfully Completes Nafdac Audit In Nigeria
Brief: Norris Medicines Says Bombay High Court Allows Criminal Appeal By Norris Medicines
Brief: Norris Medicines Designates Vimal D. Shah As Chairman, MD
Norris Medicines recalls toxic syrups, says only sold in India